Recommendations for treatment and prevention of herpes zoster and associated pain in aged adults

被引:2
作者
Lang, P. -O. [1 ,2 ]
Ferahta, N. [1 ]
机构
[1] CHU Vaudois, Serv Geriatrie & Readaptat Geriatr, Mt Paisible 16 MP16-04-414, CH-1011 Lausanne, Switzerland
[2] Anglia Ruskin Univ, Hlth & Wellbeing Acad, Cambridge CB1 1PT, England
来源
REVUE DE MEDECINE INTERNE | 2016年 / 37卷 / 01期
关键词
Herpes zoster; Acute neuralgia; Postherpetic neuralgia; Treatment; Old adults; PERIPHERAL NEUROPATHIC PAIN; POSTHERPETIC NEURALGIA; DOUBLE-BLIND; PHARMACOLOGICAL-TREATMENT; DIABETIC-NEUROPATHY; GABAPENTIN; MANAGEMENT; EFFICACY; VACCINE; DULOXETINE;
D O I
10.1016/j.revmed.2015.08.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Initiated within the first 72 hours of the rash, prescribing antiviral drugs reduces both acute neuralgia (AN) and later complications and especially postherpetic neuralgia (PHN). But their analgesic as well as preventative effect on AN and PHN is modest. Combination with analgesic drugs is more often needed for pain management. However, the pharmacological management of pain, in the context of old patients' frailty, co-morbidities and often polypharmacy, must be carefully considered. Based on analyses of the evidences from the literature, this review presents the therapeutic options we have at one's disposal and proposes a stepwise management for both AN and PHN specifically designed for aged population. (C) 2015 Societe nationale francaise de medecine interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:35 / 42
页数:8
相关论文
共 50 条
  • [41] Zoster-associated pain
    Yoon, Kyung Bong
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2008, 51 (06): : 536 - 542
  • [42] Efficacy of Patient-Controlled Intravenous Analgesia with Esketamine for Herpes Zoster Associated with Breakthrough Pain
    Tang, Jiayi
    Zhang, Enming
    Huang, Bing
    Fei, Yong
    Yao, Ming
    PAIN PHYSICIAN, 2023, 26 (03) : 299 - 306
  • [43] Pain and its persistence in herpes zoster
    Dworkin, RH
    Portenoy, RK
    PAIN, 1996, 67 (2-3) : 241 - 251
  • [44] Pain and its assessment in herpes zoster
    Dworkin, RH
    ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1997, 8 : 31 - 36
  • [45] Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia
    Gillian M. Keating
    BioDrugs, 2016, 30 : 243 - 254
  • [46] Risk of Herpes Zoster in Relation to Body Mass Index Among Residents Aged ≥50 Years: The Shozu Herpes Zoster Study
    Kawahira, Kazuhiro
    Imano, Hironori
    Yamada, Keiko
    Takao, Yukiko
    Mori, Yasuko
    Asada, Hideo
    Okuno, Yoshinobu
    Yamanishi, Koichi
    Iso, Hiroyasu
    JOURNAL OF EPIDEMIOLOGY, 2022, 32 (08) : 370 - 375
  • [47] Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials
    Kim, Joon Hyung
    Johnson, Robert
    Kovac, Martina
    Cunningham, Anthony L.
    Amakrane, Mohamed
    Sullivan, Keith M.
    Dagnew, Alemnew F.
    Curran, Desmond
    Schuind, Anne
    PAIN, 2023, 164 (04) : 741 - 748
  • [48] RF-New Recombinant Vaccine for the Prevention of Herpes Zoster
    Morgado-Carrasco, D.
    Fusta-Novell, X.
    Giavedoni, P.
    ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (01): : 67 - 68
  • [49] An inverse correlation of VZV skin-test reaction, but not antibody, with severity of herpes zoster skin symptoms and zoster-associated pain
    Asada, Hideo
    Nagayama, Kousuke
    Okazaki, Aiko
    Mori, Yasuko
    Okuno, Yoshinobu
    Takao, Yukiko
    Miyazaki, Yoshiyuki
    Onishi, Fumitake
    Okeda, Masayuki
    Yano, Shuichiro
    Kumihashi, Hideaki
    Gomi, Yasuyuki
    Maeda, Kazuhiro
    Ishikawa, Toyokazu
    Iso, Hiroyasu
    Yamanishi, Koichi
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2013, 69 (03) : 243 - 249
  • [50] Health care expenditure burden of persisting herpes zoster pain
    Dworkin, Robert H.
    White, Richard
    O'Connor, Alec B.
    Hawkins, Kevin
    PAIN MEDICINE, 2008, 9 (03) : 348 - 353